1) type 1 diabetic osteoporosis
1型糖尿病骨质疏松大鼠
1.
Loss of bone mineral content has been recognized as one reason of the type 1 diabetic osteoporosis.
本研究在建立1型糖尿病骨质疏松大鼠模型的基础上，通过体外破骨细胞培养，观察破骨细胞对1型糖尿病大鼠骨质疏松形成的影响，进一步研究第三代二膦酸盐类药物阿仑膦酸钠（alendronate,固邦）对体外破骨细胞的作用，从细胞水平探讨1型。
2) Diabetic osteoporosis
糖尿病骨质疏松
1.
Objective:To observe the effects of glucose on the differentiation of osteoclast derived from rat bone marrow cells,and to study the role of glucose in pathogenesis of diabetic osteoporosis.
目的观察葡萄糖对大鼠骨髓破骨细胞(OC)分化的影响,探讨糖尿病骨质疏松的发病机制。
3) type 2 diabetes with osteoporos
糖尿病骨质疏松
1.
Objective:To observe the effect of Tanggukang on bone density(BMD),fasting blood glucose(FBG), glycosylated hemoglobin,the bone gla protein(BGP)in serum of patients of type 2 diabetes with osteoporos.
目的:观察糖骨康对糖尿病骨质疏松患者骨密度(BMD)、空腹血糖(FBG)、糖化血红蛋白和血清骨钙素(BGP)含量的影响。
2.
Objectior:To observe the effect of Tanggukang on bone density(BMD),fasting blood glucose(FBG),glycosylated hemoglobin(HbA1c),the content of bone gla protein(BGP),bone alkaline phosphatase(BALP),insulin-like growth factor 1(IGF-1) in the serum and calcium(Ca),phosphours(P),Urine protein(PRO)in urine of patients of type 2 diabetes with osteoporos.
目的:观察糖骨康对糖尿病骨质疏松患者骨密度(BMD)、空腹血糖(FBG)、糖化血红蛋白(HbA1 c)和血清骨钙素(BGP)、骨碱性磷酸酶(BALP)、胰岛素样生长因子-1(IGF-1)以及24h尿蛋白(PRO)、尿钙(Ca)、尿磷(P)含量的影响。
4) T1DM rat
1型糖尿病大鼠
1.
The Relationship between change of telomerase activity,telomere length and Ins content in T1DM rat pancreatic island β-cell;
1型糖尿病大鼠胰岛β-细胞中端粒酶活性、端粒长度变化与血中Ins含量关系的研究
5) Diabetic osteoporosis
糖尿病性骨质疏松症
1.
To study the characteristics of clinical syndromes in diabetic osteoporosis and its early diagnostic and therapeutic methods.
为了解糖尿病性骨质疏松症患者的临床证候特点 ,探讨其早期诊断思路与治法 ,对 42例患者进行临床症状、体征调查及证候辨证 ,结果显示肾虚髓亏、脾气不足、血行不畅在所有患者中均存在 ,为糖尿病性骨质疏松症的主证 ,提示该病的治则应以益肾、健脾、补髓、壮骨、活血相结合 ,临床可以根据其主证及常见症状作出早期诊
2.
To study the clinical effects of QIANGGUBAO(QGB) on diabetic osteoporosis(DOP),the changes of clinical symptoms and bone density in 40 cases before and after being treated with DOP were observed.
为了解强骨宝对糖尿病性骨质疏松症 ( DOP)的临床疗效 ,对 4 0例 DOP患者进行强骨宝颗粒剂用药前后临床症状、骨密度等指标变化的观察。
6) diabetic osteoporosis
糖尿病性骨质疏松
1.
Recently, many studies show that the incidence of diabetic osteoporosis(DO) was much higher than other chronic complications of diabetes.
近些年的研究表明，糖尿病性骨质疏松发病率远远高于其它并发症，引起全身性骨痛，易发生骨折，致残致死率高，已引起医学专家和临床工作者的广泛重视。
2.
Objective:To investigate the regulating action and its mechanism of Bushenzhuanggu Capsule(BC) on bone resorption-formation discoupling in Diabetic Osteoporosis(DO) rats models induced by Alloxan(ALX) intraperitoneally.
目的：探讨补肾壮骨胶囊对糖尿病性骨质疏松(DO)模型大鼠骨吸收—形成解耦联的调节作用及其机制。
补充资料：骨质疏松
骨质疏松
单位体积内骨组织量减少，骨小梁数目减少，但存在的骨组织有正常的钙化，无骨膜下骨质吸收，一般钙盐和基质呈正常比例。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条